Sunitinib in pancreatic neuroendocrine tumors: Updated progression-free survival and final overall survival from a phase III randomized study

Annals of Oncology

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2g8FXvE
via IFTTT